Kymera Therapeutics, Inc.
IRAK4 DEGRADERS AND USES THEREOF

Last updated:

Abstract:

The present invention relates to a method of treating autoimmune/autoinflammatory diseases and hematological malignancies in a subject.

Status:
Application
Type:

Utility

Filling date:

15 Feb 2022

Issue date:

1 Sep 2022